Search
Close this search box.

The Importance of Integration in HealthTech Clinical Trials

HealthTech, or healthcare technology, has revolutionized the way clinical trials are conducted in the medical field. With the integration of...

In the world of healthcare and clinical research, the use of technology has become increasingly important in collecting and analyzing...

Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that accounts for approximately 15% of all...

Relyvrio, a controversial drug used to treat ALS (amyotrophic lateral sclerosis), is being pulled off the market by its maker,...

Pharmacovigilance is a crucial aspect of the healthcare industry that focuses on monitoring and assessing the safety of pharmaceutical products....

A groundbreaking Phase 2a clinical trial of regenerative cell therapy for end-stage liver disease has recently begun, with the first...

Wet age-related macular degeneration (AMD) is a chronic eye disease that can cause severe vision loss in older adults. It...

A new study published in Drugs.com MedNews has shown promising results for a transdermal microporation system using zolmitriptan in the...

Migraines are a debilitating neurological condition that affects millions of people worldwide. Characterized by severe headaches, nausea, and sensitivity to...

According to a recent report by Drugs.com MedNews, there has been a concerning increase in suicide rates among adolescents and...

Women have been making significant strides in the field of technology in recent years, breaking barriers and shattering stereotypes along...

In recent years, there has been a growing push for more diversity and inclusion in the tech industry. One area...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all cases....

Integrated research platform trials have become increasingly popular in the field of clinical research, as they offer a more efficient...

Drug-Resistant Gonorrhea Cases Triple in China, Presenting Global Health Risk Gonorrhea, a sexually transmitted infection caused by the bacterium Neisseria...

The development of new chemical entities (NCEs) is a complex and costly process in the pharmaceutical industry. However, there is...

Kidney dialysis is a life-saving treatment for individuals suffering from kidney failure. It works by removing waste, toxins, and excess...

Kidney dialysis is a life-saving treatment for individuals suffering from kidney failure. It works by removing waste, toxins, and excess...

LMK Clinical Research, LLC is proud to offer self-paced eLearning courses on the basics of Trial Master File (TMF) management....

The National Institutes of Health (NIH) has recently established a new Cancer Screening Research Network (CSRN) to evaluate and improve...

The Society of Clinical Research Associates (SOCRA) is set to host its first-ever Digital Clinical Trials (DCT) Conference in April,...

Endometriosis is a common gynecological condition that affects millions of women worldwide. It occurs when tissue similar to the lining...

Bedbugs are small, reddish-brown insects that feed on the blood of humans and animals. They are notorious for infesting homes...

In recent years, advancements in technology have revolutionized the way healthcare professionals collect and analyze patient data. From wearable devices...

The Food and Drug Administration (FDA) has recently approved a groundbreaking new drug called Rezdiffra for the treatment of a...

The Food and Drug Administration (FDA) has recently approved a groundbreaking new drug called Rezdiffra for the treatment of a...

In recent years, industry-academia partnerships have become increasingly popular as a way to bridge the gap between research and commercialization....

The recent Leadership Summit held in New Delhi brought together key stakeholders from the healthcare industry to discuss the important...

The latest research presented at the AD/PD 2024 conference has shed new light on the importance of early treatment initiation...

The Food and Drug Administration (FDA) has recently approved Praluent (alirocumab) injection for the treatment of a genetic form of...

Frequency of Citations in Future Research for Retracted microRNA Biomarker Articles

MicroRNAs (miRNAs) have gained significant attention in the field of biomarker research due to their potential role in various diseases, including cancer, cardiovascular diseases, and neurological disorders. However, the credibility of miRNA biomarker studies has come under scrutiny in recent years, with a growing number of articles being retracted due to issues such as data manipulation, lack of reproducibility, and ethical concerns.

A recent study published in the journal Nature Communications examined the frequency of citations in future research for retracted miRNA biomarker articles. The researchers analyzed a total of 50 retracted articles that were originally published between 2008 and 2018 and compared their citation rates to a control group of non-retracted articles.

The results of the study revealed that retracted miRNA biomarker articles continued to be cited in future research, with an average of 7.2 citations per retracted article compared to 11.4 citations per non-retracted article. This finding raises concerns about the impact of retracted articles on the scientific community and the potential for misinformation to be perpetuated in the literature.

One possible explanation for the continued citation of retracted miRNA biomarker articles is the lack of awareness among researchers about the retraction status of these studies. In many cases, retracted articles are not clearly marked as such in databases and may still appear in literature reviews and meta-analyses, leading to their continued use as references in new research.

Another factor that may contribute to the citation of retracted articles is the pressure to publish in academia. Researchers are often judged based on their publication record, and the inclusion of high-impact articles in their bibliography can enhance their reputation and career prospects. As a result, some researchers may be tempted to cite retracted articles without thoroughly vetting their credibility.

To address this issue, it is essential for journals and databases to clearly mark retracted articles and provide information about the reasons for retraction. Additionally, researchers should exercise caution when citing previous studies and verify the validity of the findings before incorporating them into their own research.

In conclusion, the frequency of citations in future research for retracted miRNA biomarker articles highlights the need for greater transparency and accountability in scientific publishing. By raising awareness about the pitfalls of citing retracted articles and promoting a culture of integrity and rigor in research, we can ensure that the scientific literature remains a reliable source of knowledge for future generations.